The first Castle Biosciences trade was made in Q4 2019.
Since then Cathie Wood bought shares four more times and sold shares on six occasions. The investor completely sold their stake between Q2 2021 and Q2 2022.
Avg closing price
Price range
Sold -1.17 Million shares
Q2 2022
Avg closing price
$23.24
Price range
$16.00
-
$45.99
Sold 3.6% shares (-43.1 Thousand shares)
Q1 2022
Avg closing price
$41.32
Price range
$33.17
-
$46.98
Sold 41.0% shares (-845 Thousand shares)
Q4 2021
Avg closing price
$52.25
Price range
$39.06
-
$67.58
Sold 18.5% shares (-468 Thousand shares)
Q3 2021
Avg closing price
$70.37
Price range
$60.13
-
$77.60
Sold 2.8% shares (-71.7 Thousand shares)
Q2 2021
Avg closing price
$66.05
Price range
$50.07
-
$76.78
Increased shares by 25.6% (+529 Thousand shares)
Q1 2021
Avg closing price
$75.16
Price range
$58.92
-
$97.33
Increased shares by 362.0% (+1.62 Million shares)
Q4 2020
Avg closing price
$54.21
Price range
$43.60
-
$73.05
Sold 5.5% shares (-26 Thousand shares)
Q3 2020
Avg closing price
$44.49
Price range
$38.47
-
$52.03
Increased shares by 114.9% (+253 Thousand shares)
Q2 2020
Avg closing price
$34.17
Price range
$27.28
-
$43.01
Increased shares by 7.0% (+14.4 Thousand shares)
Q1 2020